Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Brussels - Delayed Quote EUR

BioSenic S.A. (BIOS.BR)

0.0013
0.0000
(0.00%)
At close: April 25 at 5:35:04 PM GMT+2

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
NameTitlePayExercisedYear Born
Ms. Alexia Rieger Chief Investor Relation Officer -- -- 1996
Dr. Lieven Huysse M.D. Chief Medical Officer -- -- 1969

BioSenic S.A.

Building H (box 24)
Rue GranbonprE 11
Mont-Saint-Guibert, 1435
Belgium
32 493 09 73 66 https://www.biosenic.com
Sector: 
Healthcare
Industry: 
Biotechnology

Description

BioSenic S.A., a biotech company, focuses on developing clinical assets. Its technologies include cutting-edge allogeneic cell and gene therapy platform with differentiated bone marrow sourced mesenchymal stromal cells, which can be stored at the point of use in the hospital; and Arsenic TriOxide platform for use in immuno-oncology to treat graft-versus-host disease, systemic lupus erythematosus, and systemic sclerosis. The company's investigational medicinal product is ALLOB, which is in a Phase IIb clinical trial in patients with difficult tibial fractures' and ArsciCor, which is in Phase III in GvHD is being prepared with an oral treatment. BioSenic S.A. is based in Mont-Saint-Guibert, Belgium.

Corporate Governance

BioSenic S.A.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

April 28, 2025 at 10:59 AM UTC - May 9, 2025 at 12:00 PM UTC

BioSenic S.A. Earnings Date

Recent Events

Related Tickers

CYAD.BR Celyad Oncology SA
0.4810
+0.21%
 
AS00.F European Medical Solutions
4.6200
-11.80%
 
9TD.F Arctic Bioscience AS
0.3500
+8.02%
 
8E8.F Elicera Therapeutics AB (publ)
0.3200
+11.69%
 
OXUR.BR Oxurion NV
0.0799
-6.98%
 
DBV.F DBV Technologies S.A.
1.4680
-1.48%
 
POXEL.PA Poxel S.A.
0.4125
-3.73%
 
HYL.BR Hyloris Pharmaceuticals SA
6.30
-0.74%
 
PHARM.AS Pharming Group N.V.
0.7450
+1.22%
 
GLPG.AS Galapagos NV
23.40
+1.83%